Ministry of Law and Justice rejects pharma marketing rules
The rejection is a setback for public health groups that have been pushing for rules on marketing to curb bribery and corruption
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus Cadila to market anti-psychotic drug
The drug is used to treat schizophrenia and the manic symptoms of bipolar disorder, has received US FDA approval
Prega News partners with SpiceJet
Exclusive offers from booking tickets to inflight services will make expecting mothers' journey memorable
Prega News, the…
Lupin launches generic Seroquel XR tabs in US
It is indicated for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder
Glenmark receives ANDA approval for Triamcinolone Acetonide Ointment
It is the generic version of Kenalog Ointment, 0.1 per cent, of Mylan Pharmaceuticals
Eisai Pharma to cater to the Japanese market
Launches new anti-epileptic drug Fycompa (perampanel) in India
Eisai Pharmaceuticals, in order to cater to the Japanese market,…
DRL out-licenses DFD-06 to Encore Dermatology
The drug is intended to be used for treatment of moderate to severe plaque psoriasis.
Zydus Cadila gets final US FDA nod for Pindolol tabs
The drug will be manufacture at the groups manufacturing facility at the Pharma SEZ in Ahmedabad
Indian patent office grants patent to Pfizer for Prevnar 13
The granting of this patent would block other manufacturers in India from supplying this vaccine
Lupin receives EIR from US FDA
The company's Aurangabad facility underwent inspection in April 2017
Lupin has received notification that the inspection carried…